Insulin Glargine + Lixisenatide

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Insulin Glargine insulin-glargine
Lixisenatide lixisenatide

Brands with this exact combination

Brand	Composition & strength	Manufacturer
Soliqua 100/33CA MX US	injection ×2 Insulin Glargine 100 unit + Lixisenatide 0.033 mg liquid Insulin Glargine + Lixisenatide	SANOFI-AVENTIS CANADA INC
SULIQUA PRECARGADAES	injection Insulin Glargine 100 IU/1 mL + Lixisenatide 0.033 mg/1 mL injection Insulin Glargine 100 IU/1 mL + Lixisenatide 0.05 mg/1 mL	Sanofi Winthrop Industrie
insulina glargina + lixisenatidaES	100 IU/1 mL / 0.033 mg/1 mL / 0.05 mg/1 mL	Sanofi Winthrop Industrie
Soliqua solution for injection 100 units+33μgTW	injection ×2 Insulin Glargine + Lixisenatide	賽諾菲股份有限公司
SOLIQUA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100UNITS/ML + 50MCG/MLSG	injection Insulin Glargine 100 unit/mL + Lixisenatide 33 mcg/mL injection Insulin Glargine 100 unit/mL + Lixisenatide 50 mcg/mL	SANOFI-AVENTIS SINGAPORE PTE. LTD.
insulin glargine and lixisenatideUS	100 unit / 0.033 mg	Sanofi-Aventis U.S. LLC
Suliqua 100units/ml / 50micrograms/ml solution for injection 3ml pre-filled SoloStar pensGB	injection Insulin Glargine 3 mL + Lixisenatide	Sanofi
Insulin glargine 100units/ml / Lixisenatide 50micrograms/ml solution for injection 3ml pre-filled disposable devicesGB	3 mL	Sanofi
Suliqua 100units/ml / 33micrograms/ml solution for injection 3ml pre-filled SoloStar pensGB	injection Insulin Glargine 3 mL + Lixisenatide	Sanofi
Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devicesGB	3 mL	Sanofi
爽胰達注射劑100單位+33微克TW	injection Insulin Glargine + Lixisenatide	賽諾菲股份有限公司
爽胰達注射劑100單位+50微克TW	injection Insulin Glargine + Lixisenatide	賽諾菲股份有限公司
SOLIQUA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100 UNITS/ML + 33 MICROGRAMS/MLHK	unknown Insulin Glargine + Lixisenatide	SANOFI HONG KONG LIMITED
SOLIQUA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100 UNITS/ML + 50 MICROGRAMS/MLHK	unknown Insulin Glargine + Lixisenatide	SANOFI HONG KONG LIMITED
SuliquaEU	unknown Insulin Glargine + Lixisenatide	Sanofi Winthrop Industrie
ソリクア配合注ソロスターJP	injection Insulin Glargine + Lixisenatide	サノフィ

Same combination in other markets

No product with this combination is recorded in the other covered markets yet.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.